logo
Share SHARE
FONT-SIZE Plus   Neg

Two People Awarded $9 Mln Each In Accutane Case

A New Jersey jury on Friday awarded $9 million each to two people who took the anti-acne drug Accutane, made by Hoffmann-La Roche (RHHBY.PK), and developed bowel disease. Accutane causes inflammatory bowel disease in some individuals.

This was the eighth Accutane case to go to trial in the U.S. To date, plaintiffs have won over $78 million in verdicts against Roche.

The trial lasted almost two months. The jury turned back the claims of two other clients as it found that although Roche failed to warn their prescribing physicians of the dangers of Accutane, they would have been prescribed and taken Accutane anyway.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT